American Headache Society Recommends CGRP-Targeting Therapies as a First-Line Treatment

March 11, 2024 

National Headache Foundation supports the American Headache Society (AHS) efforts on behalf of patients and caregivers.  With advocacy efforts from the migraine community, favorable momentum continues with 45% of commercial health plans/PBMs aligned covering CGRPs for prevention with no step edits.   We are expecting this to increase to 60% over the next few months.  

To hear how the AHS strives to improve the lives of people impacted by migraine and other headache disorders.  

To learn even more, please tune into the following audio podcasts at: Talking Head Pain with Host:  Joe Coe from the Global Healthy Living Foundation:  

Talking Head Pain: Joe Coe and AHS. New Position Statement 

  • Host:  Joe Coe, Global Healthy Living Foundation 
  • Guest:  Dr. Andrew Charles – American Headache Society Leadership 

Talking Head Pain. Joe Coe and AHS. Access to New Migraine Medications 

  • Host:  Joe Coe, Global Healthy Living Foundation 
  • Guests:  Dr. Jessical Ailani and Dr. Stewart Tepper – American Headache Society Leadership 
  • AHS Position Statement, March 2024 
  • Patient advocacy will continue to ensure that more  
Insurance and Pharmacy Coverage
Commercial Plan Formularies